Category: New products
-
NIH Trial Testing Current Drugs to Treat Covid-19
A clinical trial is planned to assess two drugs designed for other medical conditions as treatments for Covid-19 infections.
-
Individual Cells Explored with Virtual Reality
A new software package uses virtual reality to allow biologists and medical researchers to visualize and explore inside individual cells in three dimensions.
-
Start-Up Gains Access to Vaccine Nasal Spray Technology
A company developing techniques to deliver vaccines like Covid-19 with a nasal spray received an opportunity to license the process from University of Houston.
-
New Funds Advance Hand-Wrist Neural Rehab Device
Developers of a system to help people with spinal cord injuries regain use of their hands and wrists, are configuring the device for home use.
-
Process Tests Thousands of Covid-19 Samples at Once
A new technology makes possible simultaneous analysis of diagnostic specimens from thousands of individuals revealing the presence of SARS-CoV-2 coronaviruses.
-
Stimulation Device Shown to Reduce Tinnitus Symptoms
Results from a clinical trial show a device that sends audio and electrical signals to the ears and tongue reduces tinnitus symptoms for as long as one year.
-
Microbiome Therapies Company Unveils, Raises $50M
A new enterprise is underway developing therapeutics targeting bacterial communities in the body, to treat metabolic disorders and cancer.
-
BARDA Funding Vaccine Patch Clinical Trial
The U.S. government’s medical preparedness agency is funding a clinical trial of a patch that dispenses vaccines with a much lower dose than syringes.
-
Int’l Lab Network to Assess Covid-19 Vaccines
Six clinical testing laboratories worldwide plan to evaluate vaccines for protecting against Covid-19 infections with a common set of test protocols.
-
Wireless Sensor Detects Multiple Covid-19 Indicators
Biomedical engineers designed a lab-on-a-chip sensor that quickly detects SARS-CoV-2 viruses in saliva or blood, as well as antibodies and indicators of disease severity.